Securities
We're currently building out coverage for Swiss-listed stocks (SIX Swiss Exchange). Other markets will follow.

Bachem Holding AG

CH1176493729 · BANBSIX · CH · Healthcare · Stock

Bachem Holding AG is a Swiss biopharmaceutical company headquartered in Bubendorf, Switzerland, specializing in the development and manufacture of peptides and oligonucleotides for the pharmaceutical and biotechnology industries. The company supplies active pharmaceutical ingredients (APIs) and provides peptide chemistry services across the full development lifecycle, from early research through to commercial-scale production. Bachem is recognized as one of the world's leading independent providers of peptide-based APIs and has a global presence with facilities across Europe, North America, and Asia.

Dividend Yield

0.60%

TTM · SIX

Last Dividend

0.45

CHF · 2026-05-04

5Y Growth

CAGR

Frequency

Annual

Years Paid

4

consecutive

Not Cut

2

consecutive yrs

Grown

2

consecutive yrs

Listings

Exchange Ticker Currency Yield TTM
SIX primary
BANB CHF 0.60%

Total Return

Starting Amount 10'000 CHF
Price Gain +136 CHF
Dividends +61 CHF
Total Return +1.96%
CAGR +1.96%
End Balance 10'196 CHF

Based on 10,000 invested at the start of the period. Price return uses split-adjusted closing prices. Dividends are not reinvested.

Annual Dividends

2026 CHF 0.45
2023
2024
2025
2026

Annual dividend per share · 4 years of data

Advertisement

Dividend Yield History

Loading yield history…
0.0%3.3%6.7%10.0%

Dividend History

Ex-Date Pay-Date Amount Type
04.05.202606.05.20260.45 CHFOrdinary
05.05.202507.05.20250.42 CHFOrdinary
26.04.202430.04.20240.40 CHFOrdinary
21.04.202325.04.20230.38 CHFOrdinary
21.04.202325.04.20230.37 CHFOrdinary